RESEARCH TRIANGLE INSTITUTE
The Darbepoetin Kindergarten Development Study
The Darbepoetin Kindergarten Development Study is a funding opportunity from RESEARCH TRIANGLE INSTITUTE, up to 2108079, closing August 31, 2028.
Aug 31, 2028
(762d left)Overview
PROJECT SUMMARY/ABSTRACT Improved survival of very preterm infants has not translated into improved neurodevelopment at school age. One promising neuroprotective therapy is the use of erythropoiesis stimulating agents (ESAs) such as darbepoetin. Preclinical and preliminary clinical data suggest that darbepoetin…